Cellular Therapy Nurse Coordinator

Position: Cellular Therapy Nurse Coordinator I
Working at Moffitt is both a career and a mission: to contribute to the prevention and cure of cancer.

As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt employs some of the best and brightest minds from around the world. Join a dedicated team of nearly 11,000 who are shaping the future we envision. Moffitt has been recognized as a Best and Brightest Company to Work For in the Nation and is continually named one of the Tampa Bay Times’ Top Workplaces.

Summary Cellular Therapy Nurse Coordinator I (CTNC I) is an Oncology Nursing patient therapy coordination position for an experienced registered nurse who will serve as primary nurse in the outpatient setting for a designated population of patients in the Blood and Marrow Transplant and Cellular Immunotherapy Program (BMTCI). These are cancer patients, sickle cell patients, or other patients that require bone marrow transplant or another cellular immunotherapy.

The BMTCI Program is rapidly growing and changing, flexibility and emotional intelligence is required.

Typical diseases seen within this clinic include lymphoma, leukemia, multiple myeloma, myelodysplastic syndrome, sickle cell disease, aplastic anemia. They may also include solid cancers such as Melanoma, sarcoma, lung cancer, breast cancer, gynecologic and testicular cancers. Patients may be in the period from initial consult through long term follow up and even transition into survivorship care. Under the mentorship of an assigned Cellular Therapy Nurse Coordinator II hereafter CTNC II, The CTNC I progressively increase performance to act independently in the utilization of excellent organization, multitasking, communication, and critical thinking skills to work within an assigned patient care team to coordinate the patient experience.

This coordination includes the scheduling, accuracy, and follow up on all work up orders and procedures and follow up on all ancillary teams. The nurse will assist with patient and caregiver education, communicating with all stakeholders verbally, written and electronically. Working in clinic and performing ongoing assessments, nursing interventions, maintaining documentation and fee charges in accordance with organizational standards and regulatory guidelines and performing patient education.

The candidate will strictly adhere to standard operating procedures, policies, REMs training guidelines, and the Foundation for Accreditation of Cellular Therapy guidelines.

The activities of the CTNC include the coordination of care for autologous transplant patients which includes vital organ testing coordination and patient education. Coordinating insurance authorization for each of the phases of care. Scheduling of patients for cellular collection and arranging the appropriate admission date. The CTNC will also coordinate allogeneic transplants which include the above-mentioned coordination as well as working up a stem cell donor.

The donor could be related and collected at Moffitt Cancer Center or be unrelated and collected by the national marrow donor program. Careful attention will be applied to ensure recipient and donor alignment. The CNTC will also be responsible for coordinating the care for patients requiring chimeric antigen receptor therapy or other immunotherapies. This process includes consulting with the patient, arranging for insurance authorization, vital organ testing, cellular collection, and admission coordination.

This therapy also includes collaboration with outside pharmaceutical companies through their individual portals. This is done to arrange collection, manufacturing and delivery of cellular products while ensuring patient readiness for therapy.

Activities also include astute understanding of individual insurance requirements and how that impacts coordination of the patient. Ability to utilize electronic calendars and EHR to coordinate patient care efficiently and effectively. Maintaining excellent communication with patients, their outside providers, and the whole medical team er standing of chemotherapy regimen and how that impacts the coordination process. Primary Moffitt nurse for all team patients until the patient is no longer being followed ntaining exceptional attention to details for each patient going through therapy within the BMTCI Program.

The CTNC also interacts closely with the BMTCI research team and is often part of the clinical trial activities.

The Blood and Marrow Transplant and Cellular…